What is Healthcare Mittelhessen?

Education, research, economy: The intensive networking in the health sector and medicine makes the location Central Hessen special throughout Germany. We want to link this networking in the healthcare sector even more closely with the Mittelhessen brand in order to convince new investors, specialists and cooperation partners of the successful medical industry location of Mittelhessen.

The University of Marburg has the largest department for Pharmacy in Germany.

With turnover of four billion euros and export ratio of over 90 percent, Hessen is one of the supporting pillars of the German medical technology industry.

Around 150 Central Hessian companies are specialized in the field of pharma and medical technology.

With around 9,600 employees the Universitätsklinikum Gießen/Marburg (UKGM) is the largest medium-sized Hessian company and the third largest university hospital in Germany.

Latest Storys

Prof. Dr. Werner Seeger, Medical Director of the UKGM, talks about his experiences from the Corona pandemic, the importance of lung research and the potential of digitization and AI in his research.
Millions of people with chronic respiratory diseases such as asthma and COPD are among the most vulnerable to the corona pandemic. The best protection is offered by an optimally adjusted therapy of the inflamed lung areas - and this could receive an innovative boost through Nasal Long-Term Inhalation therapy (NLI
A good idea is the first step in setting up a business. But it is only one aspect that leads to corporate success. In an interview, Jens Fuerbeth from Volksbank Mittelhessen explains what makes good financial advice for healthcare start-ups.
Insect research is a Giessen success story: Experts expect innovative solutions for global challenges. The State of Hessen is now providing further funding for the region’s scientific efforts.
The new MacTRAP mouse line allows researchers to closely study ‘hidden’ renal macrophages. These results open up new possibilities for the diagnosis of inflammatory diseases.
Die Deutsche Forschungsgemeinschaft (DFG) unterstützt mit 13,84 Millionen Euro ein Forschungskonsortium aus Mittelhessen, das nach neuen Strategien zur Behandlung von tödlichen und bislang unheilbaren Lungenhochdruck sucht.

AI in medicine: Marburg leading the way

04.03.2020

A pioneer in international AI research, Prof. Dr. Martin Hirsch takes the helm at Philipps University and the University Hospital in Marburg. With this newly created professorship, Marburg leads the way as a model region for AI-supported medicine.
Learn more ...

A world first in Lich: Asklepios Hospital implants an 'intestinal pacemaker'

19.02.2020

It's a milestone in treating fecal incontinence: For the first time, an MRI-capable intestinal pacemaker was implanted in a patient at the Licher branch of Asklepios Hospitals. This breakthrough is great news for patients who have to undergo intestinal MRIs regularly.
Learn more ...

Implementation of the EU Medical Device Regulation well underway

12.02.2020

Expected bottlenecks don't manifest: More and more medical device manufacturers are "MDR-ready". For everyone else, MedTech Europe has now published concrete recommendations.
Learn more ...



Banner HCM